Tourette Syndrome: Evolving Concepts

被引:132
作者
jankovic, Joseph [1 ,2 ]
Kurlan, Roger [3 ]
机构
[1] Baylor Coll Med, Parkinsons Dis Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Movement Disorders Clin, Dept Neurol, Houston, TX 77030 USA
[3] Overlook Hosp, Atlantic Neurosci Inst, Movement Disorders Program, Summit, NJ USA
基金
美国国家卫生研究院;
关键词
attention deficit disorder; obsessive compulsive disorder; tics; Tourette syndrome; DEEP BRAIN-STIMULATION; DOUBLE-BLIND; BOTULINUM TOXIN; BASAL GANGLIA; TIC DISORDERS; TETRABENAZINE; CHILDREN; PREVALENCE; THERAPY; MATTER;
D O I
10.1002/mds.23618
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tourette syndrome is a common childhood-onset neurobehavioral disorder characterized by multiple motor and phonic tics affecting boys more frequently than girls. Premonitory sensory urges prior to tic execution are common, and this phenomenon helps to distinguish tics from other hyperkinetic movement disorders. Tourette syndrome is commonly associated with attention deficit hyperactivity disorder, obsessive-compulsive disorder, learning difficulties, and impulse control disorder. The pathophysiology of this complex disorder is not well understood. Involvement of basal ganglia-related circuits and dopaminergic system has been suggested by various imaging and postmortem studies. Although it is considered a genetic disorder, possibly modified by environmental factors, an intense search has thus far failed to find causative genes. Symptomatic treatment of tics chiefly utilizes various alpha adrenergic agonists, antidopaminergic drugs, topiramate, botulinum toxin, and deep brain stimulation. Habit reversal therapy and other behavioral approaches may be a reasonable option for some cases. Improved understanding of Tourette syndrome should lead to better symptomatic and more effective pathogenesis-targeted therapies. (C) 2011 Movement Disorder Society
引用
收藏
页码:1149 / 1156
页数:8
相关论文
共 72 条
[1]   Sequence variants in SLITRK1 are associated with Tourette's syndrome [J].
Abelson, JF ;
Kwan, KY ;
O'Roak, BJ ;
Baek, DY ;
Stillman, AA ;
Morgan, TM ;
Mathews, CA ;
Pauls, DA ;
Rasin, MR ;
Gunel, M ;
Davis, NR ;
Ercan-Sencicek, AG ;
Guez, DH ;
Spertus, JA ;
Leckman, JF ;
Dure, LS ;
Kurlan, R ;
Singer, HS ;
Gilbert, DL ;
Farhi, A ;
Louvi, A ;
Lifton, RP ;
Sestan, N ;
State, MW .
SCIENCE, 2005, 310 (5746) :317-320
[2]   Deep brain stimulation in Tourette's syndrome [J].
Ackermans, Linda ;
Temel, Yasin ;
Visser-Vandewalle, Veerle .
NEUROTHERAPEUTICS, 2008, 5 (02) :339-344
[3]   Motor-Phonic Tic Mimicking Essential Palatal Myoclonus [J].
Adam, Octavian R. ;
Ferrara, Joseph M. ;
Jankovic, Joseph .
MOVEMENT DISORDERS, 2009, 24 (13) :2030-2032
[4]   Striatal [11C] dihydrotetrabenazine and [11C] methylphenidate binding in Tourette syndrome [J].
Albin, R. L. ;
Koeppe, R. A. ;
Wernette, K. ;
Zhuang, W. ;
Nichols, T. ;
Kilbourn, M. R. ;
Frey, K. A. .
NEUROLOGY, 2009, 72 (16) :1390-1396
[5]   Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders [J].
Allen, AJ ;
Kurlan, RM ;
Gilbert, DL ;
Coffey, BJ ;
Linder, SL ;
Lewis, DW ;
Winner, PK ;
Dunn, DW ;
Dure, LS ;
Sallee, FR ;
Milton, DR ;
Mintz, MI ;
Ricardi, RK ;
Erenberg, G ;
Layton, LL ;
Feldman, PD ;
Kelsey, DK ;
Spencer, TJ .
NEUROLOGY, 2005, 65 (12) :1941-1949
[6]   Deep brain stimulation in Tourette's syndrome [J].
Bajwa, Rizma Jalees ;
de Lotbiniere, Alain J. ;
King, Robert A. ;
Jabbari, Bahman ;
Quatrano, Susan ;
Kunze, Kimberly ;
Scahill, Lawrence ;
Leckman, James F. .
MOVEMENT DISORDERS, 2007, 22 (09) :1346-1350
[7]  
Baumer T, 2010, MOV DISORD
[8]   Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study [J].
Biederman, Joseph ;
Krishnan, Suma ;
Zhang, Yuxin ;
McGough, James J. ;
Findling, Robert L. .
CLINICAL THERAPEUTICS, 2007, 29 (03) :450-463
[9]  
Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63
[10]   Malignant Tourette syndrome [J].
Cheung, Min-Yuen Cynthia ;
Shahed, Joohi ;
Jankovic, Joseph .
MOVEMENT DISORDERS, 2007, 22 (12) :1743-1750